TherapeutAix/Medicines Discovery Catapult session on drug discovery in fibrotic disease at the BOS Basel event in Switzerland

BOS (Biotech Outsourcing Strategies) Basel 2019 will bring together stakeholders in pharmaceutical R&D outsourcing, who share knowledge, develop skills and build new and existing relationships with those in the field.

The event will cover Drug Discovery Outsourcing and Development Stage CMC Outsourcing for both Small Molecules and Biologics.

BOS Basel 2019 will take place on 19th-20th June in Basel, Switzerland, at the Congress Centre in the heart of the city.

The title of the session, scheduled on Thursday 20th June at 11.30-12.30, is:

Bridging capability gaps in drug discovery in fibrotic disease: A workshop approach to identifying capability gaps and initiate collaborations to bridge these gaps.’

The workshop, conducted in March 2019, hosted by Medicines Discovery Catapult, was led by the TherapeutAix team, with participation from key stakeholders, including representatives from CROs and Pharma. The session will describe the workshop objectives, process and output from different participant perspectives and highlight future opportunities for collaboration in capability development and validation.

Registration can be completed online and several 2019 packages are available.

Click here to register online for the event.

We’d like to send you our company updates, invites to events and any other relevant news. By providing your details and subscribing to this list, you are giving us your consent to send you these updates.

We’ll always be mindful of how often we send our updates and you can amend your preferences at any time.

We’ll never sell or swap your data with any organisation and we’ll store your details securely, respecting your trust and privacy. Please view our privacy policy for further details.

Marketing Permissions
Please select all the ways you would like to hear from TherapeutAix:
You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.